Stem cell study is a field that is very arguable. Debate in the path of stem cell study and the characteristics of general health care are a small number of of the topics looked at by health policy experts and individuals dealing with life-altering diseases like diabetes and migraine. The biggest subject concerned, is the origins of these cells. The supplies of stem cells are assorted. They can originate from adults, umbilical cord blood harvesting, and embryos.
The cure for diabetes, as well as more improved treatments, may lie in stem cell research. The American Diabetes Association supports this type of research, and has worked diligently to obtain funding. The American Diabetes Association is also fighting to eliminate bans on stem cell research pertaining to diabetes.
UC Berkeley and Stanford University are two institutions that are coming together on a venture to support collaboration among scientists who perform stem cell research.
Doctors, biologists, chemists, engineers and computer scientists from the two schools previously mentioned, are coming together to discuss their work and to share it with students and faculty.
Both universities are deeply caught up in embryonic stem cell research, which scientists anticipate will provide treatments or cures for such diseases as diabetes, Alzheimer’s and Parkinson’s.
As a symbol of their new partnership, the campuses aim to reserve space in their stem cell laboratories for stopover researchers who want to use their sabbaticals functioning with colleagues at the other school.
A biotechnology company, VistaGen Therapeutics, Inc., make use of embryonic stem cell technologies to discover and create new drugs for diabetes, publicized an extensive embryonic stem cell research unification with Toronto’s University Health Network, Canada’s foremost research hospital, and its stem cell research associate, the McEwen Centre for Regenerative Medicine.
VistaGen has been positioned to carry on with influencing the knowledge about embryonic stem cell biology as well as Dr. Gordon Keller’s technology about stem cell. Dr. Gordon Keller is one of the prominent figures in the stem cell research and he is also the McEwen Centre for Regenerative Medicine’s director. Dr. Keller and VistaGen look forward to highly developed techniques that would tell the difference in the stem cells for full grown beta-islet cells in liver, cardiac and pancreas. Furthermore, it is anticipated that the research about toxicology application about bioinformatics databases and vitro biological systems will be improved.
This research program can be seen on the licenses of Dr. Keller which were provided by VistaGen. These licenses were given for the intellectual property of the former embryonic stem cell. These also include research and findings about the recent embryonic stem cells.
VistaGen also is hoping to use the results of this research to develop the next generation of its adapted embryonic stem cell-based heart, liver and pancreatic beta-islet cell differentiation systems for discovering innovative drugs to treat heart disease, liver disease and diabetes.
Yet another group of researchers from the Spring Point Project has been leading efforts to provide a cure by injecting insulin-producing islet cells from pigs into diabetics. Research showed that transplanting healthy human islet cells in diabetics could turn around the disease. But due to a shortage of human donor organs access is limited to such cells.
Dr. Bernhard Hering, a world-renowned diabetes expert and scientific director of the Diabetes Institute for Immunology and Transplantation at the University of Minnesota, and his panel experimented with pig islet cell transplants on monkeys and discovered that those cell transplants resulted in long-term diabetes reversal in the monkeys. A PowerPoint presentation included a chart that depicted erratic blood sugar counts in the monkeys getting to a level point. The use of pig parts in humans has been doing well in other areas, including pig valves or bowels in transplants. Pig skin is also used in burn centers to substitute human skin.
Due to the fact that this is introducing foreign cells into a body, those receiving the transplants would have to take medication to make sure they did not reject the cells. There could be side effects, but at this time, it is unknown how serious they could be, and the side effects could vary from patient to patient.
Sooner, the very first experiment on the different severities of diabetes will be clinically tried especially to those who cannot check their blood sugar levels constantly. These people are also those who experience different episodes of the disease.
Stem cell research will remain a heated topic for a long time as the source of the cells remains the same as they are right now. Providing the stem cells can be obtained from a supply that the community is at ease with, the debate may cool down.
About the Author:
Julia Hanf author of the book How To Play the diabetes diet Game and Win Through a real life crisis Julia figured out how to live diabetes free. Visit http://www.yourdiabetescure.com and learn more about your solution for diabetes.
Posted in 
Tags: